Cargando…
Cognitive dysfunction in autoimmune rheumatic diseases
For people with chronic autoimmune rheumatic diseases (AIRD), such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or systemic sclerosis (SSc), normal cognitive functions are essential for performing daily activities. These diseases may be associated with cognitive dysfunction (CD)....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158026/ https://www.ncbi.nlm.nih.gov/pubmed/32293528 http://dx.doi.org/10.1186/s13075-020-02180-5 |
_version_ | 1783522454647341056 |
---|---|
author | Oláh, Csaba Schwartz, Noa Denton, Christopher Kardos, Zsófia Putterman, Chaim Szekanecz, Zoltán |
author_facet | Oláh, Csaba Schwartz, Noa Denton, Christopher Kardos, Zsófia Putterman, Chaim Szekanecz, Zoltán |
author_sort | Oláh, Csaba |
collection | PubMed |
description | For people with chronic autoimmune rheumatic diseases (AIRD), such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or systemic sclerosis (SSc), normal cognitive functions are essential for performing daily activities. These diseases may be associated with cognitive dysfunction (CD). In RA, CD has been associated with age, lower education and disease duration and activity. Great advances have been achieved in neuropsychiatric SLE in the identification of pathogenic pathways, assessment and possible treatment strategies. SSc rarely exerts direct effects on the brain and cognitive function. However, the psychological burden that includes depression, anxiety and social impact may be high. AIRD patients with sustained disease activity, organ damage or lower education should be evaluated for CD. The control of systemic inflammation together with tailored behavioural cognitive therapies may benefit these patients. |
format | Online Article Text |
id | pubmed-7158026 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71580262020-04-20 Cognitive dysfunction in autoimmune rheumatic diseases Oláh, Csaba Schwartz, Noa Denton, Christopher Kardos, Zsófia Putterman, Chaim Szekanecz, Zoltán Arthritis Res Ther Review For people with chronic autoimmune rheumatic diseases (AIRD), such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or systemic sclerosis (SSc), normal cognitive functions are essential for performing daily activities. These diseases may be associated with cognitive dysfunction (CD). In RA, CD has been associated with age, lower education and disease duration and activity. Great advances have been achieved in neuropsychiatric SLE in the identification of pathogenic pathways, assessment and possible treatment strategies. SSc rarely exerts direct effects on the brain and cognitive function. However, the psychological burden that includes depression, anxiety and social impact may be high. AIRD patients with sustained disease activity, organ damage or lower education should be evaluated for CD. The control of systemic inflammation together with tailored behavioural cognitive therapies may benefit these patients. BioMed Central 2020-04-15 2020 /pmc/articles/PMC7158026/ /pubmed/32293528 http://dx.doi.org/10.1186/s13075-020-02180-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Oláh, Csaba Schwartz, Noa Denton, Christopher Kardos, Zsófia Putterman, Chaim Szekanecz, Zoltán Cognitive dysfunction in autoimmune rheumatic diseases |
title | Cognitive dysfunction in autoimmune rheumatic diseases |
title_full | Cognitive dysfunction in autoimmune rheumatic diseases |
title_fullStr | Cognitive dysfunction in autoimmune rheumatic diseases |
title_full_unstemmed | Cognitive dysfunction in autoimmune rheumatic diseases |
title_short | Cognitive dysfunction in autoimmune rheumatic diseases |
title_sort | cognitive dysfunction in autoimmune rheumatic diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158026/ https://www.ncbi.nlm.nih.gov/pubmed/32293528 http://dx.doi.org/10.1186/s13075-020-02180-5 |
work_keys_str_mv | AT olahcsaba cognitivedysfunctioninautoimmunerheumaticdiseases AT schwartznoa cognitivedysfunctioninautoimmunerheumaticdiseases AT dentonchristopher cognitivedysfunctioninautoimmunerheumaticdiseases AT kardoszsofia cognitivedysfunctioninautoimmunerheumaticdiseases AT puttermanchaim cognitivedysfunctioninautoimmunerheumaticdiseases AT szekaneczzoltan cognitivedysfunctioninautoimmunerheumaticdiseases |